IGIB vs MYCI
iShares Trust iShares 5-10 Year Investment Grade Corporate Bond ETF against SSGA Active Trust State Street My2029 Corporate Bond ETF: cost, size, returns, what they hold and how much of it is the same.
Overlap by weight
0%
0 shared positions
Fee gap
11 bp
IGIB is cheaper
1-year return gap
3.5 pts
MYCI is ahead
Larger fund
IGIB
$19.3B
Side by side
| IGIB | MYCI | |
|---|---|---|
| Fund | iShares Trust iShares 5-10 Year Investment Grade Corporate Bond ETF | SSGA Active Trust State Street My2029 Corporate Bond ETF |
| Issuer | iShares | State Street SPDR |
| Category | Investment-Grade Corporate | Investment-Grade Corporate |
| Expense ratio | 0.04% | 0.15% |
| Assets | $19.3B | $39M |
| Average daily dollar volume | $209M | $1.7M |
| Listed | Jan 5, 2007 | Sep 23, 2024 |
| FrenzyCap score | 98 | 58 |
| 1-month return | −1.5% | −0.4% |
| 3-month return | −2.9% | −1.1% |
| Year to date | −6.0% | −2.9% |
| 1-year return | −6.9% | −3.3% |
| 30-day volatility | 5.5% | 2.4% |
| Worst drawdown, 1 year | −8.1% | −3.9% |
| Trailing 12-month yield | 5.11% | 4.60% |
| Holdings | 3,057 | 207 |
| Top 10 weight | 1.9% | 16.3% |
| Look-through P/E | — | — |
| Holdings vs fair value | — | — |
| Holdings above 200-day average | — | — |
| Net flow, latest 3 reported months | +$344M thru May 2026 | +$3.7M thru May 2026 |
| 30-day implied volatility | 10.6% | — |
| Holdings as of | as of Oct 20, 2026issuer data | as of Oct 20, 2026issuer data |
Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.
Largest shared holdings
0% of IGIB · 0% of MYCINo holdings in common.
Sector mix of the stock holdings
No sector breakdown: these funds hold few classified stocks.
More: full overlap table · IGIB holdings · MYCI holdings
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.